$AKTX Balance Sheet | Understand Stock

$AKTX

$7.63 -$0.59 (7.23%) Close

$AKTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015
ASSETS
Current assets:
Cash
Short-term investments
Prepaid expenses and other current assets
Receivable from related party
Deferred financing costs
Restricted cash
Prepaid expenses
Other current assets
Total current assets
Property and equipment, net

Goodwill
Other intangible assets
Patent acquisition costs, net
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accounts payable - related party
Accrued expenses
Loans payable - shareholders
Liability related to stock options and warrants
Convertible notes, net
Convertible notes, related party
Notes payable, net
Liability related to deposits received for share subscriptions
Notes payable, related party
Warrant liabilities
Other current liabilities
Total current liabilities

Other long-term liability
Derivative liability
Other non-current liabilities
Deferred tax liability
Total liabilities
Shareholders’ equity:
Authorized: 4,365,687,180,943 and 761,963,201,733 ordinary shares at June 30, 2026, and December 31, 2025; issued and outstanding: 140,032,769,533 and 90,536,879,533 ordinary shares at June 30, 2026, and December 31, 2025, respectively
Additional paid-in capital
Capital redemption reserve
Accumulated other comprehensive loss
Accumulated deficit
Total shareholders’ equity
Total liabilities and shareholders’ equity

Comments